Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics™, a new drug class combining the properties and benefits of antibodies and small molecules.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD3.6b (Public information from Oct 2019)
Cambridge Massachusetts (HQ)
Authorizing premium user...